HKG:6821 Market Cap

HKG:6821 has a market cap or net worth of 43.92 billion as of September 30, 2025. Its market cap has increased by 87.52% in one year.

Market Cap

43.92B

Enterprise Value

35.67B

Revenue

6.90B

Ranking

n/a

PE Ratio

37.56

Stock Price

98.65

Market Cap Chart

Since November 18, 2016, HKG:6821's market cap has increased from 5.59B to 43.92B, an increase of 685.66%. That is a compound annual growth rate of 26.16%.

Market Cap History

Date	Market Cap	% Change
Sep 30, 2025	43.93B	57.33%
Dec 31, 2024	27.92B	-38.76%
Dec 29, 2023	45.59B	-23.48%
Dec 30, 2022	59.58B	-56.36%
Dec 31, 2021	136.53B	58.47%
Dec 31, 2020	86.15B	157.03%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Nov 18, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines AG	279.26B
Hansoh Pharmaceutical Group Company	214.55B
JD Health International	206.50B
WuXi Biologics	160.93B
Innovent Biologics	160.31B
Sino Biopharmaceutical	142.12B
Akeso	124.26B
Sichuan Kelun-Biotech Biopharmaceutical	115.57B

Market Cap Rankings